Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials
{{output}}
Background: An abnormal increase of contrast-enhancing lesion (CEL) counts on frequent MRIs is interpreted as a signal of potential worsening in multiple sclerosis (MS) clinical trials. We demonstrate the utility of the MR person... ...
